Giuseppe A. Colloca - Publications

Global health status time to deterioration after systemic treatments of advanced gastric cancer: a systematic review and trial-level analysis.

Journal: Current medical research and opinion

Published: August 27, 2026

Six-month progression-free survival-related tumor growth rate after upfront chemotherapy as an outcome measure and potential prognostic or stratification variable for patients with unresectable pancreatic adenocarcinoma: an exploratory study cohorts analysis.

Journal: Journal of chemotherapy (Florence, Italy)

Published: August 16, 2026

Prognostic factors and outcome measures after BRAF-directed targeted therapy of unresectable metastatic BRAFV600E colorectal cancer: a study cohort-level analysis.

Journal: Investigational new drugs

Published: August 06, 2025

Maintenance therapy in patients with unresectable metastatic colorectal cancer receiving oxaliplatin plus antiangiogenic-based induction regimen: a study cohorts analysis.

Journal: Expert review of anticancer therapy

Published: July 19, 2025

Neutrophil-to-lymphocyte ratio in unresectable or metastatic esophageal squamous cell carcinoma: a systematic review, meta-analysis and meta-regression.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: June 30, 2025

Prognostic Effect of CEA Cut-Off in Patients with Resectable Colorectal Liver Metastases: A Meta-Analysis and Meta-Regression.

Journal: Journal of gastrointestinal cancer

Published: May 04, 2025

Different outcomes by sex in metastatic gastrointestinal stromal tumor patients receiving imatinib: a trial-level analysis.

Journal: International journal of clinical oncology

Published: January 08, 2025

Outcomes and Prognostic Factors of Patients with Unresectable or Metastatic Esophageal Squamous Cell Carcinoma Undergoing Immunotherapy- Versus Chemotherapy-Based Regimens: Systematic Review and Pooled Analyses.

Journal: Journal of gastrointestinal cancer

Published: August 06, 2024

Immune Checkpoint Inhibitors Affect Post-Progression Survival of Specific Patient Subgroups With Advanced Hepatocellular Carcinoma: A Study Cohorts' Analysis.

Journal: Journal of digestive diseases

Published: July 10, 2024

Effect of Subgroups on Study Outcomes in Unresectable Hepatocellular Carcinoma Undergoing Upfront Systemic Treatment: A Meta-analysis.

Journal: American journal of clinical oncology

Published: July 09, 2024

Prognostic Effect of Performance Status on Outcomes of Patients with Colorectal Cancer Receiving First-Line Chemotherapy: A Meta-analysis.

Journal: Journal of gastrointestinal cancer

Published: November 03, 2023

Radiographic and serologic response in patients with unresectable hepatocellular carcinoma receiving systemic antineoplastic treatments: A trial-level analysis.

Journal: Cancer

Published: October 08, 2023